共 674 条
[51]
Mezzapesa DM(1998)Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators Lancet 352 1245-1251
[52]
Petruzzellis M(2006)Imaging-guided acute ischemic stroke therapy: from “time is brain” to “physiology is brain” AJNR 27 728-735
[53]
Lucivero V(2009)MR mismatch is useful for patient selection for thrombolysis: yes Stroke 40 2906-2907
[54]
Prontera M(2009)Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imaging Radiology 251 627-633
[55]
Tinelli A(2006)MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study Lancet Neurol 5 661-667
[56]
Sancilio M(2007)MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients Stroke 38 2640-2645
[57]
Carella A(2006)Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials Stroke 37 852-858
[58]
Federico F(2006)Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset Stroke 37 1227-1231
[59]
Astrup J(2005)The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 66-73
[60]
Siesjo BK(2006)Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study Ann Neurol 60 508-517